Treatment of Leg Cellulitis
The first-line treatment for typical leg cellulitis is a 5-day course of antibiotics active against beta-hemolytic streptococci, such as penicillin, amoxicillin, dicloxacillin, or cephalexin, with extension if no improvement is seen. 1
Antibiotic Selection Based on Clinical Presentation
Mild to Moderate Non-Purulent Cellulitis
- Beta-lactam monotherapy targeting streptococci is recommended as first-line treatment, as MRSA is an unusual cause of typical cellulitis 2, 1
- Options include:
- For penicillin-allergic patients, alternatives include:
Severe or High-Risk Cellulitis
- For patients with systemic symptoms, immunocompromise, or failed outpatient therapy, consider:
- For severely compromised patients, broader coverage with vancomycin plus either piperacillin-tazobactam or a carbapenem is recommended 2
MRSA Coverage Considerations
- MRSA coverage should be added only in specific scenarios 2, 1:
- Penetrating trauma
- Evidence of MRSA infection elsewhere
- Purulent drainage
- Injection drug use
- Prior MRSA exposure
- Failed beta-lactam therapy
Treatment Duration
- 5 days of antibiotic therapy is sufficient for most cases 2, 1
- Extend treatment if infection has not improved within 5 days 2
- Clinical improvement should be evident within 48-72 hours of starting appropriate therapy 4
Adjunctive Measures
- Elevate the affected area to promote gravity drainage of edema and inflammatory substances 2, 1
- Identify and treat predisposing conditions 2:
- Consider systemic corticosteroids (prednisone 40mg daily for 7 days) in non-diabetic adults to hasten resolution 2, 1
Hospitalization Criteria
- Hospitalize patients with 2:
- Systemic inflammatory response syndrome (SIRS)
- Altered mental status
- Hemodynamic instability
- Concern for deeper or necrotizing infection
- Poor adherence to therapy
- Severe immunocompromise
- Failure of outpatient treatment
Prevention of Recurrence
- For patients with ≥3-4 episodes per year despite addressing predisposing factors, consider prophylactic antibiotics 2, 1:
- Prophylactic antibiotics reduce recurrence risk by 69% while on treatment 5
- Preventive effects diminish after discontinuation of prophylaxis 5